Imagen de Portada

Developing Allosteric Inhibitors of SARS‐CoV‐2 RNA‐Dependent RNA Polymerase

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Artem Chayka, Matěj Danda, Alžběta Dostálková, Vojtěch Spiwok, Anna Klimešová, Marina Kapisheva, Michala Zgarbová, Jan Weber, Tomáš Ruml, Michaela Rumlová, Zlatko Janeba
Formato:	Artículo Open Access
Publicado:	Wiley 2024
Materias:	ChemMedChem
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Allosteric Inhibitors of SARS‐CoV‐2 RNA‐Dependent RNA Polymerase Based on N , N′ ‐Diphenylurea
por: Artem Chayka, et al.
Publicado: (2025)

C1′‐Branched Acyclic Nucleoside Phosphonates as Inhibitors of Plasmodium Falciparum 6‐Oxopurine Phosphoribosyltransferase
por: Jan Frydrych, et al.
Publicado: (2025)

Front Cover: Stabilizing Pseudouridimycin: Synthesis, RNA Polymerase Inhibitory Activity, and Antibacterial Activity of Dipeptide‐Modified Analogues (ChemMedChem 1/2024)
por: Avraz F. Anwar, et al.
Publicado: (2024)

Machine Learning‐Guided Repositioning of a SARS‐CoV‐2‐Targeting Molecular Series as Cruzain Inhibitors
por: Rafael F. Lameiro, et al.
Publicado: (2026)

Structural Basis for Inhibition of the SARS‐CoV‐2 nsp16 by Substrate‐Based Dual Site Inhibitors
por: Gints Kalnins, et al.
Publicado: (2024)

Synthesis and Characterization of DHODH Inhibitors Based on the Vidofludimus Scaffold with Pronounced Anti‐SARS‐CoV‐2 Activity
por: Christian Gege, et al.
Publicado: (2024)

Discovery of Fluorescent Naturally‐Occurring Inhibitor of SARS‐CoV‐2 Main Protease by AIE Fluorescent Probe
por: Hao Lin, et al.
Publicado: (2024)

Rational Design of Novel Allosteric EYA2 Inhibitors as Potential Therapeutics for Multiple Brain Cancers
por: Lukas Gardner, et al.
Publicado: (2024)

Design, Synthesis, and Evaluation of Novel Inhibitors of Aminoglycoside‐Resistance 16S Ribosomal RNA Methyltransferases
por: Benjamin E. Deprez, et al.
Publicado: (2025)

Small‐Molecule Allosteric Inhibitors of Human Aspartate Transcarbamoylase Suppress Proliferation of Bone Osteosarcoma Epithelial Cells
por: Chao Wang, et al.
Publicado: (2024)

Identification of Potential Inhibitors of the SARS‐CoV‐2 NSP13 Helicase via Structure‐Based Ligand Design, Molecular Docking and Nonequilibrium Alchemical Simulations
por: Giorgio Di Paco, et al.
Publicado: (2024)

Discovery of Novel Pyrido[2,3‐b]Pyrazine Human Cytomegalovirus Polymerase Inhibitors with Broad Spectrum Antiherpetic Activity and Reduced hERG Inhibition
por: Bing Bai, et al.
Publicado: (2024)

Front Cover: Rational Design of Novel Allosteric EYA2 Inhibitors as Potential Therapeutics for Multiple Brain Cancers (ChemMedChem 18/2024)
por: Lukas Gardner, et al.
Publicado: (2024)

Kainate Receptor Allosteric Modulators: State of the Art and Future Directions
por: Thomas Colson, et al.
Publicado: (2026)

Front Cover: Identification of Potential Inhibitors of the SARS‐CoV‐2 NSP13 Helicase via Structure‐Based Ligand Design, Molecular Docking and Nonequilibrium Alchemical Simulations (ChemMedChem 10/2024)
por: Giorgio Di Paco, et al.
Publicado: (2024)

Quinoline‐ and Pyrimidine‐based Allosteric Modulators of the Sarco/Endoplasmic Reticulum Calcium ATPase
por: Stefan Paula, et al.
Publicado: (2024)

Design and Discovery of Substituted 1,3,4‐Thiadiazole–1,3,5‐Triazine Hybrids as Human Immunodeficiency Virus‐1 Non‐Nucleoside Reverse Transcriptase Inhibitors with Anti‐SARS‐CoV‐2 and Antibacterial Activities
por: Saumya Singh, et al.
Publicado: (2026)

Chemical Design Strategy of Ionizable Lipids for In Vivo mRNA Delivery
por: Zepeng He, et al.
Publicado: (2024)

Exploring Small‐Molecule Modulators of Precursor miRNA Processing Associated With Glycolysis
por: Miho Fujiki, et al.
Publicado: (2026)

Fluorescence Detection of DNA/RNA G‐Quadruplexes (G4s) by Twice‐as‐Smart Ligands
por: Jiri Ledvinka, et al.
Publicado: (2025)

The Evaluation of Glyceryl C3‐Azolyl‐Thiogalactosides as Galectin‐1 and Galectin‐3 Ligands
por: Vít Prouza, et al.
Publicado: (2025)

Serum Circulating mRNA Panel for the Early Detection of Gastric Cancer: A Potential Biomarker Test
por: Xinyu Peng, et al.
Publicado: (2024)

Novel Sulfonamide‐Sydnone Hybrids: Complementary Insight into Anti‐Inflammatory Action, Anti‐SARS‐CoV‐2 Activity, Human Serum Albumin Interaction, and in silico Analysis
por: Igor Resendes Barbosa, et al.
Publicado: (2025)

The 5′ Cap Epitranscriptome and Beyond: Natural and Engineered 5′ Cap Modifications for Optimizing mRNA Therapeutics and Functional Studies
por: Greta Charlotte Dahm, et al.
Publicado: (2026)

Ligand‐Based Pharmacophore Modeling and Structure‐Based Virtual Screening for Identifying Potential Therapeutic Agents Targeting the SARS‐CoV‐2 Spike Protein‐ACE2 Receptor Interaction
por: Timoteo Delgado‐Maldonado, et al.
Publicado: (2026)

Front Cover: Novel Sulfonamide‐Sydnone Hybrids: Complementary Insight into Anti‐Inflammatory Action, Anti‐SARS‐CoV‐2 Activity, Human Serum Albumin Interaction, and in silico Analysis (ChemMedChem 9/2025)
por: Igor Resendes Barbosa, et al.
Publicado: (2025)

APH Inhibitors that Reverse Aminoglycoside Resistance in Enterococcus casseliflavus
por: Elise Kaplan, et al.
Publicado: (2025)

The Role of Protein Disulfide Isomerase Inhibitors in Cancer Therapy
por: Qiuying Nie, et al.
Publicado: (2024)

Challenges for the Discovery of Non‐Covalent WRN Helicase Inhibitors
por: Alisa Heuser, et al.
Publicado: (2024)

Small‐Molecule KRAS Inhibitors by Tyrosine Covalent Bond Formation
por: Alexander D. Landgraf, et al.
Publicado: (2025)

Binding‐Site Switch for Protein Kinase CK2 Inhibitors
por: Dylan Grenier, et al.
Publicado: (2025)

Decoding Urease Inhibition: A Comprehensive Review of Inhibitor Scaffolds
por: Nuno Martinho, et al.
Publicado: (2026)

Thiazole‐Based IL‐17 Inhibitors Discovered by Scaffold Morphing
por: Juraj Velcicky, et al.
Publicado: (2025)

Gram‐Scale Synthesis of an Arylsulfonamide‐Type Alkaline Phosphatase Inhibitor
por: Zsolt Rapi, et al.
Publicado: (2026)

Biaryl Phosphate‐Based Inhibitors of the Transcription Factor STAT4
por: Nadiya Brovchenko, et al.
Publicado: (2025)

Repurposing of Inhibitors of Plasmodial Aspartate Transcarbamoylase Toward Trypanosoma Cruzi
por: Siyao Chen, et al.
Publicado: (2026)

Balinatunfib: A Clinical Oral Small Molecule TNFα Inhibitor
por: Alexander Dömling, et al.
Publicado: (2025)

2‐Carboxyquinoline Boronic Acids as Highly Potent KPC Inhibitors
por: Zheng Ma, et al.
Publicado: (2025)

Development of New Peptidomimetic NADPH Oxidase Inhibitors with Antithrombotic Properties
por: Elisabetta Scalia, et al.
Publicado: (2024)

Structure‐Atropisomer Stability Relationship in Selective MCL‐1 Inhibitors
por: Szabolcs Sipos, et al.
Publicado: (2025)